New
HealthMore in Health→
Vosoritide Raises a Bigger Question Than Height in Achondroplasia
Key Takeaways
- Vosoritide has established evidence of increasing growth in children with achondroplasia.
- Preliminary findings suggest possible spinal and complication benefits, but do not prove lifelong outcomes.
- The treatment has prompted debate over whether height should define success in achondroplasia care.
DE
DT Editorial Team··via medicalxpress.com